ShigeUlaflexneri M90T (invasive) and BS176 (noninvasive) are typical nonfimbriated organisms that do not bind to or activate phagocytic cells. We demonstrate that S. flexneri M9OTp and BS176p, obtained by transformation of the strains named above with the cluster of genes encoding type 1 (mannose-specific) fimbriae ofEscherichia coli, express the functional fimbriae, as shown by electron microscopy, by binding of antifimbria antibodies and by yeast cell aggregation. The transformants, but not the parental strains, bound to human granulocytes and mouse peritoneal macrophages. This binding was inhibited by methyl a-D-mannoside but not by methyl a-D-galactoside. The bound bacteria induced oxidative burst activation and degranulation of the granulocytes in vitro. With mouse peritoneal macrophages, the binding of the fimbriated bacteria induced degranulation in vitro. Injection of the bacteria into mouse peritoneum also induced degranulation of the macrophages in vivo; no such effect was observed with the nonfimbriated strains. The bound fimbriated transformants were effectively killed by the human granulocytes in vitro in the absence of opsonins or after opsonization with human anti-S. flexnei antiserum. The nonfimbriated strains were killed only after opsonization. These results provide further evidence for the role of type 1 fimbriae in lectin-mediated nonopsonic phagocytosis.
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Many members of the family Enterobacteriaceae express on their surface mannose-specific lectins in the form of type 1 fimbriae which mediate the adhesion of the bacteria to mammalian cells, including phagocytes, in the absence of opsonins (26) . The sugar-specific adhesion to the phagocytes is frequently followed by activation of the oxidative burst, degranulation of the phagocytes, and the ingestion and killing of the bacteria, a phenomenon designated lectinophagocytosis (22) . Type 1 fimbriae are threadlike appendages consisting of about 1,000 protein subunits. Eight genes, from A to H, are required for the expression of the fimbriae, only one of which, the H gene, codes for the mannose-binding subunit (15) . Shigella flexneri strains are generally nonfimbriated (20) and, unless opsonized, are unable to bind to phagocytic cells or to induce an oxidative burst in these cells. Verdon et al. (27) have recently introduced a plasmid (obtained from P. E. Omdorff) which contains the cluster of Escherichia coli genes controlling the production of type 1 fimbriae into two isogenic strains of S. flexneri, the invasive M90T and the noninvasive BS176, to obtain the derivative recombinant strains M9OTp and BS176p, respectively.
In this study, we describe experiments aimed at assessing the ability of these transformants to bind to yeast cells, human granulocytes, and mouse peritoneal macrophages in the absence of opsonins in a mannose-specific manner and to cause activation of, and to be killed by, the phagocytic cells. As a control, we used type 1-fimbriated E. coli 346, which was employed previously in studies of lectinophagocytosis (2, 3, 5, 11 Media and growth conditions of bacterial strains. Transformation of the nonfimbriated strains M9OT and BS176 was done with plasmid pSH2 obtained from E. coli ORN103 provided by P. E. Omdorff. Plasmid DNA isolation was performed by the technique of Bimboim and Doly (4) . This plasmid, which contained the total type 1-fimbria operon, was transferred to the nonfimbriated strains by the method of Lederberg and Cohen (16) . S. fle-xneri transformants BS176p and M90Tp (27) were grown in Trypticase soy broth containing chloramphenicol at a final concentration of 20 p,g/ml to ensure that they retained the plasmid encoding the gene for type 1 fimbriae; parental strains BS176 and M9OT (9, 18, 24) were grown in the absence of chloramphenicol. A uropathogenic isolate of E. coli (strain 346) (19) was grown in brain heart infusion broth (Difco Laboratories, Detroit, Mich.). To obtain heavily fimbriated bacteria, the E. coli or Shigella strains were cultured at 37°C for 24 h under static conditions. The bacteria were collected by centrifugation (3, (10) . The adherent cells were incubated with 100 ,ul of PBS-CaMg containing 3% BSA for 30 min at 37°C, and the buffer was removed by aspiration. Bacteria (2 x 107 in 50 ,ul of PBS-CaMg), in the absence or presence of 100 mM MeoMan, were added to each well, and the plate was incubated at 4°C for 1 h. In parallel, the bacteria were added after opsonization with anti-Shigella antiserum. The type 1-fimbriated E. coli was added after opsonization with 10% normal human serum. The supernatant containing unbound bacteria was aspirated, and the attached cells were washed three times with ice-cold PBSCaMg. The plate was further incubated for different periods at 37°C before the attached cells were lysed with 1% sodium deoxycholate. The lysates were diluted 1:5, 1:50, and 1:500 in PBS-CaMg, and aliquots of 20 RI were plated on nutrient agar in petri dishes. Incubation was for 24 h at 37°C, at which time the number of colonies was counted. Killing of bacteria was calculated by comparing the number of colonies formed after incubation of the human granulocytes with the bacteria at 37°C to that obtained without incubation at this temperature. Incubation for 30 min at 37°C of the opsonized S. surface as shown by electron microscopy, whereas the parental strains did not (Fig. 1) . Antifimbria antibodies failed to bind the latter strains but bound readily to their transformants (Fig. 2) . The transformants aggregated yeast cells in a concentration-dependent and MeaMan-inhibitable manner (Fig. 3) . No detectable yeast cell aggregation was observed with the parental strains up to a concentration of 4 x 107 bacteria per ml.
Activation of the phagocytic cells and killing of the bacteria. Similarly to type 1-fimbriated E. coli, the fimbriated S. flexneri strains also bound to human granulocytes and mouse peritoneal macrophages in a mannose-inhibitable manner (Fig. 4) . This binding resulted in the activation of an oxidative burst of the granulocytes, as monitored by the generation of chemiluminescence. The activation was dose dependent and inhibited by MeatMan (Fig. 5) . The nonfimbriated Shigella strains M9OT and BS176 failed to activate an oxidative burst of the granulocytes but did so after opsonization with human anti-Shigella antiserum. At a bacterium/ phagocyte ratio of 144:1, the maximal activation of the oxidative burst with type 1-fimbriated E. coli was considerably higher (two to three times) than that with fimbriated S.
flexen.
The fimbriated strain BS176p induced the in vitro degranulation of human granulocytes and mouse peritoneal macrophages. Degranulation increased with an increase in the ratio of bacterium/phagocyte and was inhibited by MeaMan but not by MeaGal. The nonfimbriated strain BS176 failed to induce degranulation (Fig. 6) . Similarly, whereas strain M9OTp induced degranulation with both types of phagocytic cells, the nonfimbriated strain M9OT did not (data not shown).
Injection of BS176p into the peritoneal cavity of mice caused degranulation, as evidenced by the significant release of ,GlcNAc-ase into the peritoneal cavity, similarly to results obtained with type 1-fimbriated E. coli (3) . With the nonfimbriated strain BS176, PGlcNAc-ase release was significantly lower (Fig. 7) . Both of the fimbriated strains, M9OTp and BS176p, were extremely sensitive to killing by human granulocytes (Fig. 8) , whereas the nonfimbriated strains, M9OT and BS176, were resistant to killing under nonopsonic conditions but were sensitive to killing when opsonized with human anti-Shigella antiserum. 
DISCUSSION
The purpose of the present study was to investigate the role of type 1 fimbriae in phagocytosis of nonfimbriated and fimbriated S. flexneri as measured by binding, activation of the oxidative burst, degranulation in vitro and in vivo, and killing of the bacteria by the granulocytes. The fimbriated bacteria were obtained by transformation of the nonfimbriated strains with the cluster of genes encoding type 1 fimbriae of E. coli. The results indicate that the transformants expressed the fimbriae, as shown by electron microscopy, binding of antifimbria antibodies, and yeast cell aggregation which is inhibited by MeaMan. Moreover, the fimbriated, but not the nonfimbriated strains, bound to human granulocytes and to mouse peritoneal macrophages. This binding resulted in oxidative burst activation and degranulation of the granulocytes in vitro. With mouse peritoneal macrophages, the binding of the fimbriated bacteria induced degranulation both in vitro and in vivo. Under nonopsonic conditions, the fimbriated bacteria were effectively killed by the granulocytes, whereas the nonfimbriated bacteria were resistant even in the presence of normal human serum. Opsonization of the nonfimbriated bacteria was required to induce activation of the granulocytes and their killing of the bacteria. Our findings show that type binding of the antifimbria antibodies to S. flexneri strains as compared with E. coli. Our results add further support to other reports (1, 5, 12, 13, 17, 23, 25) , which indicate that type 1 fimbriae may have dual roles in host-pathogen interactions. In some locations, such as the gut, fimbriation appears to be an advantage for adherence and colonization.
In circulating blood, or areas rich in phagocytic cells, fimbriae may be a disadvantage for the bacteria. The expression of fimbriae has been shown to be controlled by environmental signals. That such signals differ in different habitats may explain how, in some cases, a fimbriated pathogen can evade host defenses. 
